Painful Urination Labs and Next Steps: What to Do When It Burns to Pee
Learn the common and serious causes of painful urination, which lab tests your doctor will order, and exactly what to do next. Reviewed by board-certified physicians.
Painful Urination: When to See a Doctor and What Causes It
Painful urination can signal a UTI, STI, kidney stone, or something more serious. Learn the causes, red-flag symptoms, and when to seek care immediately.
Peptide Injection Site Reactions: Drugs That Cause or Treat Them
A guide covering the drugs most likely to cause peptide injection site reactions, how to diagnose them, and evidence-based treatment and prevention strategies.
Peripheral Fatigue: What Could Be Causing It?
A guide covering the most common and serious causes of peripheral fatigue, how doctors diagnose it, and evidence-based treatment options available in 2025.
Rectal Bleeding: Drugs That Cause It, Drugs That Treat It, and When to Act
A guide to rectal bleeding: which drug classes contribute to it or make it harder to stop, which medications are used to treat its underlying causes, the red flags that mean urgent or emergency care, and what remains uncertain.
Reflux Labs and Next Steps: What Your Symptoms Mean and What to Do Now
Learn what causes reflux, which lab tests and procedures matter, when to worry, and how clinicians at HealthRX.com approach diagnosis and treatment from first symptoms to long-term management.
Scrotal Swelling: Drugs That Cause or Treat It
A clinical guide to the medications linked to scrotal swelling, the conditions that drive it, and the treatments proven to work. prepared by the HealthRX.com Editorial Team.
Cervical Radiculopathy vs Shoulder Pain: Arm Symptoms Explained
Arm pain, numbness, or weakness may signal cervical radiculopathy, not shoulder injury. See key symptom differences and when to seek same-day care.
Snoring: Drugs That Cause It, Drugs That Treat It, and When to Act
A guide to the pharmacology of snoring, which medications make it worse, which may help, and how to tell if your snoring signals obstructive sleep apnea.
Vertigo Drugs: What Causes It, What Treats It, and When to Call a Doctor
A complete clinical guide to the medications that cause vertigo and the drugs used to treat it, including dosing, trial data, and red-flag symptoms that require urgent evaluation.
How Is Vertigo Diagnosed? Dix-Hallpike Test & When to Worry
Vertigo is diagnosed with the Dix-Hallpike test to check for BPPV, the cause of most cases. Learn the red-flag symptoms that signal stroke and need ER care.
Tadalafil (Generic) Adult (30 to 49) Monitoring: Doses, Labs, and Safety Checkpoints
A guide to monitoring tadalafil 2.5 to 20 mg in adults aged 30 to 49: when to check blood pressure, PSA, liver enzymes, and cardiovascular risk, with dose-specific safety thresholds and follow-up intervals.
Tadalafil (Generic) Storage, Stability & Shelf Life: Complete Clinical Guide
How to store generic tadalafil 2.5 to 20 mg correctly, what the stability data shows, when tablets degrade, and what that means for efficacy and safety, with PubMed and FDA citations.
Tadalafil (Generic) Dosing for Young Adults (Ages 18 to 29)
A guide to tadalafil 2.5 to 20 mg dosing for men aged 18 to 29, covering on-demand vs. daily regimens, fertility considerations, BPH overlap, safety, and a clinician-discussion framework for monitoring.
Tadalafil (Generic) Mental Health and Mood Impact
A clinical deep-dive into how tadalafil 2.5 to 20 mg affects mental health, mood, anxiety, and depression, covering trial data, mechanisms, and prescribing considerations.
Tadalafil Microdosing Protocols: What the Evidence Actually Says
What tadalafil's U.S. label and clinical trials say about 2.5 mg and 5 mg once-daily dosing, how daily use differs from as-needed use, and which safety gates matter.
Tadalafil (Generic) Post-Bariatric Surgery Use: Dosing, Absorption, and Clinical Guidance
What is established, and what is not, about generic tadalafil (2.5 to 20 mg) after bariatric surgery, covering plausible pharmacokinetic changes, dose selection tradeoffs, drug interactions, and monitoring for ED and BPH indications.
Tadalafil (Generic) Rebound Effects When Stopping: What the Evidence Actually Shows
A guide on what happens when you stop tadalafil (generic, 2.5 to 20 mg), covering rebound ED, BPH symptom return, cardiovascular considerations, and how to taper safely based on current clinical evidence.
TB-500 Future Formulations & Pipeline: What's Coming for Thymosin Beta-4
A clinical-depth review of TB-500 (thymosin beta-4 active fragment) pipeline developments, emerging delivery formats, mechanism of action, and what the next generation of formulations may mean for tissue repair research.
TB-500 Monitoring Schedule: Labs & Exams Every Patient Needs
A clinician-authored guide to the complete TB-500 (thymosin beta-4 active fragment) monitoring schedule, including baseline labs, on-cycle exams, safety checkpoints, and red-flag criteria.
TB-500 Safety for Young Adults (Ages 18 to 29): What the Evidence Actually Shows
A guide to TB-500 (thymosin beta-4 active fragment) safety in the 18 to 29 age group, covering pharmacology, regulatory status, dosing protocols, fertility considerations, and what real evidence exists.
TB-500 Autoimmune Disease Considerations: What Clinicians and Patients Need to Know
A deep dive into TB-500 (thymosin beta-4 active fragment) and autoimmune disease: mechanistic risks, immune-modulation data, dosing cautions, and clinical decision points for patients with autoimmune conditions.
TB-500 Cancer Risk Signal Review: What the Evidence Actually Shows
A clinician-level review of thymosin beta-4 active fragment (TB-500) and cancer risk signals, covering preclinical tumor-promotion data, angiogenesis mechanisms, clinical gaps, and informed consent considerations for prescribers.
Egrifta (Tesamorelin) Switching Protocols: From/To Other Drugs in Class
A physician-level guide to switching tesamorelin (Egrifta) from or to other growth-hormone-releasing hormones, GH secretagogues, and GLP-1 agents in HIV-associated lipodystrophy. Covers mechanism, pharmacology, washout timing, and clinical evidence.
Egrifta (Tesamorelin): What to Expect, Week-by-Week First Month
A week-by-week guide to tesamorelin (Egrifta) during the first 30 days: injection technique, timeline of visceral fat reduction, side effects, and what lab changes to monitor.
Egrifta (Tesamorelin) Liver Function Impact: What the Clinical Evidence Shows
A deep-dive into how tesamorelin (Egrifta) affects liver function, including ALT/AST changes, hepatic fat, and NAFLD risk in HIV-associated lipodystrophy patients.
Egrifta (Tesamorelin) Travel & Timezone-Shift Protocols
MD/PharmD-level guide to traveling with tesamorelin (Egrifta): cold-chain transport, TSA rules, dose-timing adjustments across time zones, and injection technique on the road.
Testosterone Cypionate Adolescent (12 to 17) Safety: What Clinicians and Families Need to Know
A comprehensive clinical guide to testosterone cypionate safety in adolescents aged 12, 17, covering growth-plate risks, dosing protocols, mental-health monitoring, and FDA guidance.
Testosterone Cypionate: Complete Drug-Drug Interaction Profile
An evidence-based guide to every clinically significant drug interaction with testosterone cypionate, including mechanisms, severity grades, and management strategies backed by PubMed and FDA sources.
Testosterone Cypionate Geriatric (65+) Monitoring: A Clinical Guide
Complete guide to monitoring testosterone cypionate therapy in men 65 and older, covering lab schedules, cardiovascular risk, falls risk, hematocrit targets, and deprescribing thresholds backed by the T-Trials and current endocrine guidelines.
Testosterone Cypionate Monitoring for Young Adults (Ages 18 to 29)
A complete clinical guide to testosterone cypionate monitoring for men aged 18 to 29, covering labs, dosing schedules, fertility preservation, and guideline-based safety thresholds.
Testosterone Cypionate Safety in Young Adults Ages 18 to 29
A guide to testosterone cypionate safety for young adult men ages 18-29, covering fertility, bone health, cardiovascular risk, dosing, and monitoring protocols.
Testosterone Cypionate Hair and Skin Changes: What to Expect and How to Manage Them
A guide to hair and skin changes linked to testosterone cypionate therapy, including DHT-driven alopecia, acne, oily skin, and evidence-based management strategies.
Testosterone Cypionate After Bariatric Surgery: What Patients and Clinicians Need to Know
A guide to testosterone cypionate use after bariatric surgery, covering hypogonadism prevalence, dosing, monitoring, and drug absorption changes post-operatively.
Test Cyp and Insomnia: Sleep Apnea vs Better Sleep
Testosterone cypionate can improve sleep at physiologic doses but raises apnea risk at high doses. See how dose and level affect your sleep.
Testosterone Cypionate Travel & Timezone-Shift Protocols
A physician-level guide to managing testosterone cypionate injections across time zones, travel schedules, and storage constraints. Covers dose timing flexibility, cold-chain rules, airport security, and daylight-saving adjustments with primary-literature citations.
Testosterone Enanthate Adolescent (12 to 17) Safety: What Clinicians and Families Need to Know
A guide to testosterone enanthate safety in adolescents aged 12 to 17, covering FDA-approved indications, growth-plate risks, dosing protocols, monitoring schedules, and clinical evidence.
Testosterone Enanthate Monitoring for Adults Ages 30 to 49
A clinical guide to monitoring testosterone enanthate therapy in adults aged 30 to 49, covering lab schedules, dose adjustments, cardiovascular markers, hematocrit, fertility, and when to escalate care.
Testosterone Enanthate Future Formulations & Pipeline
A clinical deep-dive into what comes next for testosterone enanthate: novel delivery routes, extended-release depots, subdermal implants, nasal gels, oral prodrugs, and late-stage pipeline candidates reshaping male hypogonadism care.
Testosterone Enanthate Storage, Stability & Shelf Life
How to store testosterone enanthate: keep vials at 20-25°C (68-77°F) in the original carton, away from light, and discard 28 days after first puncture.
Testosterone Enanthate Cancer Risk Signal Review
A clinician-level review of the cancer risk signals associated with testosterone enanthate therapy, covering prostate, breast, erythrocytosis-related, and emerging data, with primary-literature citations and practical prescribing guidance.
Testosterone Enanthate and Cognitive Function: What the Evidence Actually Shows
A clinical review of testosterone enanthate's effects on cognition, memory, and mood in hypogonadal men, covering the T-Trials, mechanistic data, dosing, and monitoring protocols.
Testosterone Enanthate Hair and Skin Changes: What the Evidence Actually Shows
A clinician-level review of how testosterone enanthate affects scalp hair, body hair, sebum production, acne, and skin thickness. Covers mechanisms, timelines, management strategies, and primary-literature citations.
Testosterone Enanthate: Restarting After Acute Illness
A practical guide to restarting testosterone enanthate (TE) injections after acute illness, covering when to hold, how to restart, dose adjustments, and monitoring, with clear notes on what is established versus what needs primary-source verification.
Testosterone Enanthate Travel & Timezone-Shift Protocols
Complete clinical guide to managing testosterone enanthate injections during travel, time-zone changes, and schedule disruptions. Covers dose timing flexibility, storage, customs documentation, and injection technique on the road.
Thymosin Alpha-1 Safety in Young Adults (Ages 18 to 29): What the Evidence Actually Shows
A guide to thymosin alpha-1 (thymalfasin) safety for young adults aged 18 to 29, covering dosing, side effects, fertility considerations, and what compounded 503A protocols look like in practice.
Thymosin Alpha-1 Autoimmune Disease Considerations
A clinician-level review of thymosin alpha-1 (thymalfasin) in autoimmune disease: immunomodulatory mechanisms, trial evidence, risk-benefit analysis, dosing protocols, and monitoring parameters for prescribers.
Thymosin Alpha-1 and Cognitive Function: What the Evidence Shows
A clinician-level review of how thymosin alpha-1 (thymalfasin) may affect cognitive function, covering neuroimmune mechanisms, key trials, dosing considerations, and what patients and prescribers need to know.
Does Menopause Cause Hair Loss?
Yes, menopause can cause hair loss. Falling estrogen and progesterone levels shift hair follicles into a resting phase while rising androgen activity shrinks them. Learn the mechanisms, treatment options, and what the evidence actually shows.
AndroGel Slow Titration for Sensitivity: A Complete Dose Escalation Guide
Learn how to titrate AndroGel slowly for better tolerance, fewer side effects, and optimized testosterone levels. protocols, real doses, and primary-source citations.
Ipamorelin Re-Titration After Stopping: Dose Escalation Protocol and Clinical Guidance
How to safely re-titrate ipamorelin acetate after a break. Covers starting dose, escalation schedule, re-titration rationale, and clinical evidence from Raun et al. And real-world practice.
Low-Dose Naltrexone Max Dose, Titration, and What Comes After 4.5 mg
A clinical guide to low-dose naltrexone titration from 1.5 mg to 4.5 mg, when higher off-label doses are used, and what the RCT and real-world evidence says about dose escalation safety and efficacy.
Oral Minoxidil Max Dose: How High Can You Go and Why?
A guide to oral minoxidil titration, max-dose rationale, real-world evidence, and safety monitoring from 0.625 mg up to 5 mg and beyond.
Ozempic Re-Titration After Stopping: How to Safely Restart Semaglutide
Stopped Ozempic and need to restart? This clinical guide covers the FDA-approved re-titration schedule for semaglutide 0.5 to 2.0 mg, what the evidence says about restarting after a gap, and how to minimize side effects.
Rapamycin (Sirolimus) Slow Titration for Sensitivity: A Clinical Guide
Learn how to titrate rapamycin (sirolimus) slowly for longevity and off-label use, including starting doses, escalation schedules, side-effect monitoring, and when to pause. Reviewed by HealthRX.com physicians.
Sildenafil (Generic) Accelerated Titration: How Fast Can You Increase the Dose?
A guide to sildenafil accelerated titration, covering dose escalation from 25 mg to 100 mg, FDA labeling, RCT data, and real-world safety considerations.
Tretinoin Slow Titration for Sensitivity: The Complete Dose-Escalation Guide
Learn how to slow-titrate tretinoin to minimize purging, peeling, and irritation. Evidence-based schedule, dosing tips, and clinical data prepared by the HealthRX.com Editorial Team.
Vardenafil (Levitra/Staxyn) Re-Titration After Stopping: A Complete Clinical Guide
Learn how to safely re-titrate vardenafil (Levitra/Staxyn) after a treatment gap, including starting doses, escalation schedules, and what the evidence says about restarting PDE5 inhibitor therapy.
Wegovy Re-Titration After Stopping: How to Restart Semaglutide Safely
Learn exactly how to re-titrate Wegovy (semaglutide 2.4 mg) after a dose interruption, including FDA-label guidance, clinical trial data, and restart protocols.
Topical Minoxidil Dosing for Adults 30 to 49
Use 5% minoxidil solution 1 mL twice daily or foam half a capful once daily. Regrowth needs 16 weeks minimum, peak effect by 12 months.